
0:00
7:36
By Alan Cassels at Brownstone dot org.
This week I had to add another folder to my burgeoning disease-mongering file cabinet, and what a doozy it was.
I now have a folder I have simply labelled "NIPPLES."
I'm not making this up, given that this week I saw the disease-creation industry insert itself into a place that I had never seen it go before, inside your bra.
And what did it find in there?
The jury may be still out, but for the sake of simplicity let's just call it the Nipple of Doom.
Just this week, the UK newspaper the Guardian presented what seemed like a solemn investigation into a condition termed "Sad Nipple Syndrome," also known as SNS, for those who prefer their medicalization served with a sleek, clinical acronym that would be fun to brandish at dinner parties.
According to the Guardian, thousands of people are on Reddit reporting a phenomenon colloquially dubbed "the nipple touch of doom." The symptom? A brief, sudden wave of existential dread, nostalgia, or homesickness triggered by a light touch of the chest—whether from a towel, a shirt, or an intimate partner.
Again, I am not making this up. But I wish I were, because this story contains two things that I find endlessly fascinating; namely money, and, er, nipples.
At first glance, I thought it was parody. Then I gave my head a shake, remembering that truth is almost always stranger than fiction. SNS is the real deal, and if it follows the classic evolutionary cycle of disease-mongering, what stands as a quirky internet thing today is a precursor to a new brand-name patented pharmaceutical tomorrow.
Having been bucked off a bronco before, let me assure you, this isn't my first rodeo. I witnessed the pharma-backed disease-mongers as they created PMDD (premenstrual dysphoric disorder) back in 1994, a medicalized term that starts with bad menstrual periods and ends in a recycled antidepressant. I saw FSD (Female Sexual Dysfunction) in its embryonic state in 1998 when an international team of researchers were convening in fancy European hotels to try to figure out how to medicalize and medicate a condition we used to call "Not tonight dear, I have a headache." I remember back in 2007 when men were browbeaten with the "Low-T" cudgel in a massive direct-to-consumer ad campaign to get men to seriously think about smearing creamy testosterone on their chests to augment their manliness, i.e., their "T."
I will grant a modest concession to reality: human neurobiology is undeniably weird. Nerve pathways crisscross; chemicals such as oxytocin and dopamine spike and dip in mysterious ways, and a fraction of the population may indeed experience a fleeting, bizarre emotional hiccup when certain physical receptors are stimulated. For those individuals, the sensation may be very real, if peculiar. If a brief wave of soul-searching nostalgia hits when you put on an old hat, so be it. Human biology is full of strange, harmless glitches.
Where the satire evaporates—and the cash registers begin to ring—is found in the slick medicalese used to describe the act of turning a harmless human quirk into a tragic, underserved medical "syndrome."
This is the short three-Step sequence of classic disease-mongering unfolding right before our eyes.
Step one: Take a mild, transient, or obscure physical sensation and brand it. Get there first, because the market rewards this kind of transformative "innovation."
Step two: Locate and promote a parade of sufferers through the media who, using the same song sheet, sing a sorrowful lament of suffering that is woefully neglected by medicine due to a lack of "medical curiosity, funding, and research."
Step three: Hold a microphone to the mouths of sympathetic hand-picked experts whose skill most shines as they explain speculative, high-sounding biological mechanisms. The Guardian treats us to theories about "inappropriate dopamine activity" and oxytocin signalling pathways "going haywire."
The moment someone frames a harmless human quirk as "inappr...
This week I had to add another folder to my burgeoning disease-mongering file cabinet, and what a doozy it was.
I now have a folder I have simply labelled "NIPPLES."
I'm not making this up, given that this week I saw the disease-creation industry insert itself into a place that I had never seen it go before, inside your bra.
And what did it find in there?
The jury may be still out, but for the sake of simplicity let's just call it the Nipple of Doom.
Just this week, the UK newspaper the Guardian presented what seemed like a solemn investigation into a condition termed "Sad Nipple Syndrome," also known as SNS, for those who prefer their medicalization served with a sleek, clinical acronym that would be fun to brandish at dinner parties.
According to the Guardian, thousands of people are on Reddit reporting a phenomenon colloquially dubbed "the nipple touch of doom." The symptom? A brief, sudden wave of existential dread, nostalgia, or homesickness triggered by a light touch of the chest—whether from a towel, a shirt, or an intimate partner.
Again, I am not making this up. But I wish I were, because this story contains two things that I find endlessly fascinating; namely money, and, er, nipples.
At first glance, I thought it was parody. Then I gave my head a shake, remembering that truth is almost always stranger than fiction. SNS is the real deal, and if it follows the classic evolutionary cycle of disease-mongering, what stands as a quirky internet thing today is a precursor to a new brand-name patented pharmaceutical tomorrow.
Having been bucked off a bronco before, let me assure you, this isn't my first rodeo. I witnessed the pharma-backed disease-mongers as they created PMDD (premenstrual dysphoric disorder) back in 1994, a medicalized term that starts with bad menstrual periods and ends in a recycled antidepressant. I saw FSD (Female Sexual Dysfunction) in its embryonic state in 1998 when an international team of researchers were convening in fancy European hotels to try to figure out how to medicalize and medicate a condition we used to call "Not tonight dear, I have a headache." I remember back in 2007 when men were browbeaten with the "Low-T" cudgel in a massive direct-to-consumer ad campaign to get men to seriously think about smearing creamy testosterone on their chests to augment their manliness, i.e., their "T."
I will grant a modest concession to reality: human neurobiology is undeniably weird. Nerve pathways crisscross; chemicals such as oxytocin and dopamine spike and dip in mysterious ways, and a fraction of the population may indeed experience a fleeting, bizarre emotional hiccup when certain physical receptors are stimulated. For those individuals, the sensation may be very real, if peculiar. If a brief wave of soul-searching nostalgia hits when you put on an old hat, so be it. Human biology is full of strange, harmless glitches.
Where the satire evaporates—and the cash registers begin to ring—is found in the slick medicalese used to describe the act of turning a harmless human quirk into a tragic, underserved medical "syndrome."
This is the short three-Step sequence of classic disease-mongering unfolding right before our eyes.
Step one: Take a mild, transient, or obscure physical sensation and brand it. Get there first, because the market rewards this kind of transformative "innovation."
Step two: Locate and promote a parade of sufferers through the media who, using the same song sheet, sing a sorrowful lament of suffering that is woefully neglected by medicine due to a lack of "medical curiosity, funding, and research."
Step three: Hold a microphone to the mouths of sympathetic hand-picked experts whose skill most shines as they explain speculative, high-sounding biological mechanisms. The Guardian treats us to theories about "inappropriate dopamine activity" and oxytocin signalling pathways "going haywire."
The moment someone frames a harmless human quirk as "inappr...
Fler avsnitt från "Brownstone Journal"



Missa inte ett avsnitt av “Brownstone Journal” och prenumerera på det i GetPodcast-appen.








